Research progress of the assessment tools for fear of complications in diabetic patients

doi:10.3760/cma.j.issn.1007-1245.2022.02.033

Abstract

Abstract: We review the main content, reliability, validity, application, and limitations of the assessment tools for fear of complication in diabetic patients at home and abroad, so as to provide a reference for the development of assessment tools for fear of complication of diabetic patients in China and provide some useful information about the research on fear of complications of diabetic patients.

Key words: Diabetes mellitus, Fear of complications, Assessment tools, Nursing; Review

摘要： 综述国内外糖尿病患者并发症恐惧的评估工具的主要内容、信效度、应用情况及局限性，旨在为我国糖尿病患者并发症恐惧的评估工具的开发提供借鉴，为糖尿病患者并发症恐惧的相关研究提供参考。

关键词: 糖尿病, 并发症恐惧, 评估工具, 护理, 综述

Dai Yu , Guo Jia , Yin Chongwang , Mao Xia , Liu Yangchun. Research progress of the assessment tools for fear of complications in diabetic patients[J]. International Medicine and Health Guidance News, 2022, 28(2): 280-283.

代玉, 郭佳, 殷崇望, 毛霞, 刘阳春. 糖尿病患者并发症恐惧评估工具的研究进展[J]. 国际医药卫生导报, 2022, 28(2): 280-283.

References

[1] International Diabetes Federation. IDF Diabetes Atlas 9th Edition 2019[EB/OL]. (2019) [2019-11-20]. https:// diabetesatlas.org/en/.

[2] Saeedi P, Salpea P, Karuranga S, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2020, 162: 108086. DOI: 10.1016/j.diabres.2020.108086.

[3] Dankert A, Duran G, Engst-Hastreiter U, et al. Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis[J]. Rehabilitation (Stuttg), 2003, 42(3): 155-163. DOI: 10.1055/s-2003-40094.

[4] Taylor EP, Crawford JR, Gold AE. Design and development of a scale measuring fear of complications in type 1 diabetes[J]. Diabetes Metab Res Rev, 2005, 21(3): 264-270. DOI: 10.1002/dmrr.524.

[5] Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies[J]. J Cancer Surviv, 2013, 7(3): 300-322. DOI: 10.1007/s11764-013-0272-z.

[6] Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term ( ≧ 5 years) cancer survivors--a systematic review of quantitative studies[J]. Psychooncology, 2013, 22(1): 1-11. DOI: 10.1002/ pon.3022.

[7] Dinkel A, Herschbach P. Fear of progression in cancer patients and survivors[J]. Recent Results Cancer Res, 2018, 210: 13-33. DOI: 10.1007/978-3-319-64310-6_2.

[8] Arend F, Müller UA, Schmitt A, et al. Overestimation of risk and increased fear of long-term complications of diabetes in people with type 1 and 2 diabetes[J]. Exp Clin Endocrinol Diabetes, 2019, 127(10): 645-652. DOI: 10.1055/a-0977-2667.

[9] Green L, Feher M, Catalan J. Fears and phobias in people with diabetes[J]. Diabetes Metab Res Rev, 2000, 16(4): 287-293. DOI: 10.1002/1520-7560(2000)9999: 9999< :: aid-dmrr123>3.0.co;2-t.

[10] 马辛,赵旭东.医学心理学[M].北京:人民卫生出版社,2015: 145-170.

[11] Herschbach P, Dinkel A. Fear of progression[J]. Recent Results Cancer Res, 2014, 197: 11-29. DOI: 10.1007/ 978-3-642-40187-9_2.

[12] Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire[J]. J Psychosom Res, 2005, 58(6): 505-511. DOI: 10.1016/j.jpsychores.2005.02.007.

[13] Berg P, Book K, Dinkel A, et al. Fear of progression in chronic diseases[J]. Psychother Psychosom Med Psychol, 2011, 61(1): 32-37. DOI: 10.1055/s-0030-1267927.

[14] Lebel S, Mutsaers B, Tomei C, et al. Health anxiety and illness-related fears across diverse chronic illnesses: a systematic review on conceptualization, measurement, prevalence, course, and correlates[J]. PLoS One, 2020, 15(7): e0234124. DOI: 10.1371/journal.pone.0234124.

[15] Schmitt A, Reimer A, Kulzer B, et al. Erfassung von Angst vor diabetischen Folgekrankheiten: Reliabilität und Validität der deutschen Version des Fear of Complications Questionnaire (FCQ) [J]. Diabetologie und Stoffwechsel, 2017, 12(1):195. DOI:10.1055/s-0037-1601774.

[16] Abate TW, Gedamu H. Psychosocial and clinical factors associated with depression among individuals with diabetes in Bahir Dar City Administrative, Northwest Ethiopia[J]. Ann Gen Psychiatry, 2020, 19: 18. DOI: 10.1186/s12991-020-00267-6.

[17] Janzen Claude JA, Hadjistavropoulos HD, Friesen L. Exploration of health anxiety among individuals with diabetes: prevalence and implications[J]. J Health Psychol, 2014, 19(2): 312-322. DOI: 10.1177/1359105312470157.

[18] Madhu M, Abish A, Anu K, et al. Predictors of depression among patients with diabetes mellitus in Southern India [J]. Asian J Psychiatr, 2013, 6(4): 313-317. DOI: 10.1016/j. ajp.2013.01.012.

[19] Luckie R, Leese G, McAlpine R, et al. Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study [J]. Diabet Med, 2007, 24(10): 1086-1092. DOI: 10.1111/ j.1464-5491.2007.02180.x.

[20] Quandt SA, Reynolds T, Chapman C, et al. Older adults' fears about diabetes: using common sense models of disease to understand fear origins and implications for self-management[J]. J Appl Gerontol, 2013, 32(7): 783-803. DOI: 10.1177/0733464811435506.

[21] Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues [J]. Psychosomatics, 2002, 43(4): 259-281. DOI: 10.1176/ appi.psy.43.4.259.

[22] Thewes B, Butow P, Zachariae R, et al. Fear of cancer recurrence: a systematic literature review of self-report measures[J]. Psychooncology, 2012, 21(6): 571-587. DOI: 10.1002/pon.2070.

[23] Mehnert A, Herschbach P, Berg P, et al. Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF) [J]. Z Psychosom Med Psychother, 2006, 52(3): 274-288. DOI: 10.13109/zptm.2006.52.3.274.

[24] Herschbach P, Berg P, Waadt S, et al. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer[J]. Psychother Psychosom, 2010, 79(1): 31-38. DOI: 10.1159/000254903.

[25] Kwakkenbos L, van den Hoogen FH, Custers J, et al. Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis[J]. Arthritis Care Res (Hoboken), 2012, 64(6): 930-934. DOI: 10.1002/ acr.21618.

[26] Aghdam AM, Rahmani A, Nejad ZK, et al. Fear of cancer recurrence and its predictive factors among Iranian cancer patients[J]. Indian J Palliat Care, 2014, 20(2): 128-133. DOI: 10.4103/0973-1075.132632.

[27] Hinz A, Mehnert A, Ernst J, et al. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12[J]. Support Care Cancer, 2015, 23(6): 1579-1587. DOI: 10.1007/s00520-014-2516-5.

[28] Koch-Gallenkamp L, Bertram H, Eberle A, et al. Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? [J]. Health Psychol, 2016, 35(12): 1329-1333. DOI: 10.1037/ hea0000374.

[29] Fait K, Vilchinsky N, Dekel R, et al. Cardiac-disease-induced PTSD and fear of illness progression: capturing the unique nature of disease-related PTSD[J]. Gen Hosp Psychiatry, 2018, 53: 131-138. DOI: 10.1016/j. genhosppsych.2018.02.011.

[30] Nikendei C, Greinacher A, Berkunova A, et al. Psychological burden and resilience factors in patients with Alveolar Echinococcosis - a cross-sectional study[J]. PLoS Negl Trop Dis, 2019, 13(1): e0007082. DOI: 10.1371/journal. pntd.0007082.

[31] 吴奇云,叶志霞,李丽,等. 癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J]. 中华护理杂志,2015,50(12):1515-1519. DOI:10.3761/j.issn.0254-1769.2015.12.021.

[32] Arbeitsgemeinschaft Diabetes und Psychologie, DDG. Fear of Diabetes Complications Questionnaire (FDCQ) [EB/OL]. Retrieved from https://www. diabetes-psychologie. de/ templates/main.php?SID = 2825 on (06.12.2018)

[33] Olsen M, Anderbrot T, Amsberg S, et al. Psychometric properties of the Swedish version of the fear of complications questionnaire[J]. Open Journal of Endocrine and Metabolic Diseases, 2014, 4(4): 69-76. DOI:10.4236/ ojemd.2014.44008.

[34] Kuniss N, Freyer M, Müller N, et al. Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level[J]. Acta Diabetol, 2019, 56(1): 33-38. DOI: 10.1007/s00592-018-1217-9.

[35] Aghamohammadi-Kalkhoran M, Valizadeh S. Fears and concerns of Iranian diabetic women: a phenomenological study[J]. J Health Psychol, 2016, 21(7): 1322-1330. DOI: 10.1177/1359105314552303.

[36] Gåfvels C, Lithner F, Börjeson B. Living with diabetes: relationship to gender, duration and complications. A survey in northern Sweden[J]. Diabet Med, 1993, 10(8): 768-773. DOI: 10.1111/j.1464-5491.1993.tb00162.x.

[37] Nkyekyer EW. Relationship between concern for vision lossand self-care management in type 1 and type 2 diabetics[D].New Haven: Yale University, 2011.

[38] 王维清,崔娜,回婷,等. 糖尿病患者保护性动机及其与疾病恐惧和心理痛苦的相关性[J]. 护士进修杂志, 2019, 34(12): 1084-1088. DOI:10.16821/j.cnki.hsjx.2019.12.006. [39] 唐娇,何姗. 自我效能在2型糖尿病患者恐惧疾病进展与生存质量间的中介效应[J]. 中外医学研究,2021,19(7):160-162. DOI:10.14033/j.cnki.cfmr.2021.07.059.